🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07294313
Starting soon Observational

Harnessing Artificial Intelligence for Diagnosing Androgenetic Alopecia: A Training and Validation Study

NCT07294313 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2026-04-25
Last updated
2026-03-20

Condition(s) studied

Androgenetic Alopecia

Study summary

The aim of this study is to develop and validate deep learning models in diagnosis of male and female pattern hair loss, and assessment of its severity based on clinical and trichoscopic image by handheld dermoscopy and administrative data (age and sex).

Eligibility

Sex
ALL
Min age
12 Years
Max age
50 Years
Healthy volunteers
Accepted
for the patient group: Inclusion criteria: * Patients with male or female pattern hair loss diagnosed clinically or suspected clinically and confirmed trichoscopically * Age of disease onset 12-50 years old * Both genders * Any grade of androgenetic alopecia * Any duration of androgenetic alopecia * Any skin type Exclusion criteria by clinical and trichoscopic examination: * Patients with patchy hair loss or Telogen effluvium only. * Patients with cicatricial alopecia or diffuse alopecia areata * Patients with inflammatory scalp disorders (psoriasis, seborrheic dermatitis, lichen planopilaris and frontal fibrosing alopecia in a pattern distribution) * Lack of patient cooperation. for the control group: apparently healthy participants not suffering from the following: AGA, patchy hair loss, cicatricial alopecia, diffuse alopecia areata, inflammatory scalp disorders (psoriasis, seborrheic dermatitis, lichen planopilaris and frontal fibrosing alopecia in a pattern distribution).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine Cairo University Cairo Cairo Governorate

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07294313 on ClinicalTrials.gov ↗ ← All trials in Egypt